Aneurysm Abdominal Clinical Trial
Official title:
Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Derivo 2
This is a multicentric voluntary observational study with a retrospective evaluation of prospectively collected data concerning the treatment of visceral aneurysms with flow diversion stent Derivo Peripher and Derivo 2 (DED, Acandis GmbH) Follow-up will include clinical and radiological (CT) evaluation at least 12 months after the intervention. The enrollment period will be of 54 months (01/01/2020-30/06/2024). Minimum sample size will be of 50 Patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06206369 -
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
|
||
Completed |
NCT05141123 -
Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures
|
||
Enrolling by invitation |
NCT04269447 -
Prospective Aortic Biobank of POP-STAR
|
||
Not yet recruiting |
NCT06044480 -
Effect of Dexamethason on Postimplantation Syndrome After EVAR
|
Phase 4 | |
Completed |
NCT05519826 -
A Retrospective, Observational Study to Collect Clinical Safety and Performance Data of POLYMAILLE® EXTRA THIN Vascular Prothesis
|
||
Completed |
NCT04430114 -
MuLtibranchEd Graft for OPen RepAir of ThoRacoabdominal Aneurysms
|
N/A | |
Completed |
NCT05346289 -
Elective Treatment Rates and Surgical Non-eligibility Among Men and Women With Intact Abdominal Aortic Aneurysms
|
||
Completed |
NCT05517876 -
A Retrospective, Observational, Multicenter, Study to Collect Clinical Safety and Performance Data on POLYMAILLE®C
|
||
Completed |
NCT03484013 -
Totally Percutaneous Approach to Endovascular Treatment of Aortic Aneurysms (PEVAR-PRO)
|
||
Completed |
NCT05324657 -
Anatomical and Perioperative Predisposing Factor for Limb Occlusion of Incraft Infrarenal Endograft (LIMIT Study)
|
||
Recruiting |
NCT03727412 -
Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA
|
N/A |